Epoetin alfa biosimilar (Siam Bioscience)

阿法依伯汀生物类似药 (Siam Bioscience)

Report date: 2022/01/14 13:23:58

Base Information

Drug NameEpoetin alfa biosimilar (Siam Bioscience)

Drug Alias Name阿法依伯汀生物仿制药 (Siam Bioscience)Human erythropoietin epoetin alfa (Siam Bioscience)Recombinant Human Erythropoietin Alfa (Siam Bioscience)Hema-Plus

ClassificationBiologics > BiosimilarBiologics > Protein drugs > Recombinant protein > Recombinant cytokines

Mechanisms of ActionErythropoiesis stimulantsErythropoietin receptor agonists

TargetsErythropoietin receptor

Therapy Area/IndicationsAnemia

Global Approved IndicationsAnemia

Approved Indications in ChinaN/A

Original Approved Country/TerritoryThailand

Original Approved Date2017/11/01

Country/TerritoryThailand

CombinationsNo

Global Highest StatusApproved

Highest Status in ChinaN/A

Originator CompaniesSiam Bioscience

China Registration ClassN/A

Develop Information

Active CompaniesSiam Bioscience

Inactive CompaniesN/A

Active IndicationsAnemia

Inactive IndicationsN/A

Other Information

ATC CodeB03XA01